Oncogenic Kras and p53 mutational status control chemotherapy-induced growth factor shedding via activation of ADAM17 in colorectal cancer

Keara Redmond; Philip Dunne; Darragh McArt; Daniel Longley; Patrick Johnston; Sandra Van Schaeybroeck

Oncogenic Kras and p53 mutational status control chemotherapy-induced growth factor shedding via activation of ADAM17 in colorectal cancer

Keara Redmond, Philip Dunne, Darragh McArt, Daniel Longley, Patrick Johnston, Sandra Van Schaeybroeck

School of Medicine, Dentistry and Biomedical Sciences

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Original language	English
Title of host publication	Oncogenic Kras and p53 mutational status control chemotherapy-induced growth factor shedding via activation of ADAM17 in colorectal cancer
Publisher	National Cancer Research Institute
Publication status	Published - Nov 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

http://abstracts.ncri.org.uk/abstract/oncogenic-kras-and-p53-mutational-status-control-chemotherapy-induced-growth-factor-shedding-via-activation-of-adam17-in-colorectal-cancer-2/

Cite this

Redmond, K., Dunne, P., McArt, D., Longley, D., Johnston, P., & Van Schaeybroeck, S. (2013). Oncogenic Kras and p53 mutational status control chemotherapy-induced growth factor shedding via activation of ADAM17 in colorectal cancer. In Oncogenic Kras and p53 mutational status control chemotherapy-induced growth factor shedding via activation of ADAM17 in colorectal cancer National Cancer Research Institute. http://abstracts.ncri.org.uk/abstract/oncogenic-kras-and-p53-mutational-status-control-chemotherapy-induced-growth-factor-shedding-via-activation-of-adam17-in-colorectal-cancer-2/

Redmond, Keara ; Dunne, Philip ; McArt, Darragh et al. / Oncogenic Kras and p53 mutational status control chemotherapy-induced growth factor shedding via activation of ADAM17 in colorectal cancer. Oncogenic Kras and p53 mutational status control chemotherapy-induced growth factor shedding via activation of ADAM17 in colorectal cancer. National Cancer Research Institute, 2013.

@inproceedings{651e9952355545e482ac58db266ef71d,

title = "Oncogenic Kras and p53 mutational status control chemotherapy-induced growth factor shedding via activation of ADAM17 in colorectal cancer",

author = "Keara Redmond and Philip Dunne and Darragh McArt and Daniel Longley and Patrick Johnston and {Van Schaeybroeck}, Sandra",

year = "2013",

month = nov,

language = "English",

booktitle = "Oncogenic Kras and p53 mutational status control chemotherapy-induced growth factor shedding via activation of ADAM17 in colorectal cancer",

publisher = "National Cancer Research Institute",

}

Redmond, K , Dunne, P, McArt, D, Longley, D, Johnston, P & Van Schaeybroeck, S 2013, Oncogenic Kras and p53 mutational status control chemotherapy-induced growth factor shedding via activation of ADAM17 in colorectal cancer. in Oncogenic Kras and p53 mutational status control chemotherapy-induced growth factor shedding via activation of ADAM17 in colorectal cancer. National Cancer Research Institute. <http://abstracts.ncri.org.uk/abstract/oncogenic-kras-and-p53-mutational-status-control-chemotherapy-induced-growth-factor-shedding-via-activation-of-adam17-in-colorectal-cancer-2/>

Oncogenic Kras and p53 mutational status control chemotherapy-induced growth factor shedding via activation of ADAM17 in colorectal cancer. / Redmond, Keara ; Dunne, Philip; McArt, Darragh et al.
Oncogenic Kras and p53 mutational status control chemotherapy-induced growth factor shedding via activation of ADAM17 in colorectal cancer. National Cancer Research Institute, 2013.

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

TY - GEN

T1 - Oncogenic Kras and p53 mutational status control chemotherapy-induced growth factor shedding via activation of ADAM17 in colorectal cancer

AU - Redmond, Keara

AU - Dunne, Philip

AU - McArt, Darragh

AU - Longley, Daniel

AU - Johnston, Patrick

AU - Van Schaeybroeck, Sandra

PY - 2013/11

Y1 - 2013/11

M3 - Conference contribution

BT - Oncogenic Kras and p53 mutational status control chemotherapy-induced growth factor shedding via activation of ADAM17 in colorectal cancer

PB - National Cancer Research Institute

ER -

Redmond K , Dunne P, McArt D, Longley D, Johnston P, Van Schaeybroeck S. Oncogenic Kras and p53 mutational status control chemotherapy-induced growth factor shedding via activation of ADAM17 in colorectal cancer. In Oncogenic Kras and p53 mutational status control chemotherapy-induced growth factor shedding via activation of ADAM17 in colorectal cancer. National Cancer Research Institute. 2013